VSIQQ®


Solution for injection
scheduling status
S4
registration number
54/15.4/0489
What VSIQQ® contains
brolucizumab 120 mg/ml.
other ingredients
Sodium citrate, Sucrose, Polysorbate 80, Water for injection.
Therapeutic classification
S01LA06.
© 2026 SAHPRA. ALL RIGHTS RESERVED